2799m Ivakaftor

On behalf of the four regional health authorities, Sykehusinnkjøp HF, division pharmaceuticals, is considering to procure the active ingredient ivacaftor. Sykehusinnkjøp would like to invite inetessenter to dialogue meetings to update us in the market. The meetings will be held via Teams on the 8th and/or the 9th of June 2018. By 3 September 2026, interested parties 2026.Vi to register their interest in such a dialogue meeting via the communication module in Ivalua.